Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4265 - 4272 of 12008 results
Middle Market Private Equity Fund Strategies for Managing Portfolio Company Defaults
April 10, 2020| Advisory| Viewpoint
Traders Accused of Profiting From Hack Agree to Settle With SEC
April 10, 2020| News
FINRA Agrees with SEC Regarding Enforcement of Regulation BI in Light of COVID-19
April 10, 2020| Blog| Viewpoint
New Federal Financing Facilities Announced for Certain Municipal Issuers and Corporate Borrowers
April 10, 2020| Advisory| Viewpoint
A Review of the Affordable Care Act at 10 Years, Part 4: Alternative Payment and Delivery Models
April 10, 2020| Blog| Viewpoint
Law360's 2020 Immigration Editorial Advisory Board
April 10, 2020| News
ML Strategies COVID-19 Insights Week In Review — April 10, 2020
April 10, 2020| Article| Viewpoint
CARES Act Creates and Updates Drug and Medical Device Shortage Requirements
April 9, 2020| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|